238 related articles for article (PubMed ID: 11401583)
41. Inhibition of tryptase release from human colon mast cells by protease inhibitors.
He SH; Xie H
World J Gastroenterol; 2004 Feb; 10(3):332-6. PubMed ID: 14760752
[TBL] [Abstract][Full Text] [Related]
42. Interaction of human mast cell tryptase and chymase with low-molecular-mass serine proteinase inhibitors from the human respiratory tract.
Hochstrasser K; Gebhard W; Albrecht G; Rasp G; Kastenbauer E
Eur Arch Otorhinolaryngol; 1993; 249(8):455-8. PubMed ID: 8442939
[TBL] [Abstract][Full Text] [Related]
43. Effects of human mast cell tryptase and eosinophil granule proteins on the kinetics of blood clotting.
Samoszuk M; Corwin M; Hazen SL
Am J Hematol; 2003 May; 73(1):18-25. PubMed ID: 12701115
[TBL] [Abstract][Full Text] [Related]
44. Glycosylation and the activation of proteinase-activated receptor 2 (PAR(2)) by human mast cell tryptase.
Compton SJ; Renaux B; Wijesuriya SJ; Hollenberg MD
Br J Pharmacol; 2001 Oct; 134(4):705-18. PubMed ID: 11606310
[TBL] [Abstract][Full Text] [Related]
45. Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine.
He S; Peng Q; Walls AF
J Immunol; 1997 Dec; 159(12):6216-25. PubMed ID: 9550425
[TBL] [Abstract][Full Text] [Related]
46. Histone-tryptase interaction: H2A N-terminal tail removal and inhibitory activity.
Fiorucci L; Erba F; Ascoli F
Arch Biochem Biophys; 1997 Nov; 347(2):229-34. PubMed ID: 9367529
[TBL] [Abstract][Full Text] [Related]
47. Mast cell tryptase, a still enigmatic enzyme.
Fiorucci L; Ascoli F
Cell Mol Life Sci; 2004 Jun; 61(11):1278-95. PubMed ID: 15170507
[TBL] [Abstract][Full Text] [Related]
48. A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I.
Sakai K; Ren S; Schwartz LB
J Clin Invest; 1996 Feb; 97(4):988-95. PubMed ID: 8613553
[TBL] [Abstract][Full Text] [Related]
49. Regulation of human mast cell beta-tryptase: conversion of inactive monomer to active tetramer at acid pH.
Ren S; Sakai K; Schwartz LB
J Immunol; 1998 May; 160(9):4561-9. PubMed ID: 9574563
[TBL] [Abstract][Full Text] [Related]
50. Stem cell factor-dependent human cord blood derived mast cells express alpha- and beta-tryptase, heparin and chondroitin sulphate.
Nilsson G; Blom T; Harvima I; Kusche-Gullberg M; Nilsson K; Hellman L
Immunology; 1996 Jun; 88(2):308-14. PubMed ID: 8690466
[TBL] [Abstract][Full Text] [Related]
51. Synthesis of potent and selective 2-azepanone inhibitors of human tryptase.
Zhao G; Bolton SA; Kwon C; Hartl KS; Seiler SM; Slusarchyk WA; Sutton JC; Bisacchi GS
Bioorg Med Chem Lett; 2004 Jan; 14(2):309-12. PubMed ID: 14698147
[TBL] [Abstract][Full Text] [Related]
52. Mast cell tryptase: a new target for therapeutic intervention in asthma.
Tanaka RD; Clark JM; Warne RL; Abraham WM; Moore WR
Int Arch Allergy Immunol; 1995; 107(1-3):408-9. PubMed ID: 7613193
[No Abstract] [Full Text] [Related]
53. Influence of heparin, protamine and polybrene on the time integral of thrombin generation (endogenous thrombin potential).
Rotteveel RC; Roozendaal KJ; Weijers RN; Eijsman L
Haemostasis; 1996; 26(1):1-10. PubMed ID: 8698272
[TBL] [Abstract][Full Text] [Related]
54. Formation of enzymatically active, homotypic, and heterotypic tetramers of mouse mast cell tryptases. Dependence on a conserved Trp-rich domain on the surface.
Huang C; Morales G; Vagi A; Chanasyk K; Ferrazzi M; Burklow C; Qiu WT; Feyfant E; Sali A; Stevens RL
J Biol Chem; 2000 Jan; 275(1):351-8. PubMed ID: 10617625
[TBL] [Abstract][Full Text] [Related]
55. Cyclotheonamide E4 and E5, new potent tryptase inhibitors from an Ircinia species of sponge.
Murakami Y; Takei M; Shindo K; Kitazume C; Tanaka J; Higa T; Fukamachi H
J Nat Prod; 2002 Mar; 65(3):259-61. PubMed ID: 11908961
[TBL] [Abstract][Full Text] [Related]
56. Mast cells limit extracellular levels of IL-13 via a serglycin proteoglycan-serine protease axis.
Waern I; Karlsson I; Thorpe M; Schlenner SM; Feyerabend TB; Rodewald HR; Åbrink M; Hellman L; Pejler G; Wernersson S
Biol Chem; 2012 Dec; 393(12):1555-67. PubMed ID: 23667909
[TBL] [Abstract][Full Text] [Related]
57. 1,2-Benzisothiazol-3-one 1,1-dioxide inhibitors of human mast cell tryptase.
Combrink KD; Gülgeze HB; Meanwell NA; Pearce BC; Zulan P; Bisacchi GS; Roberts DG; Stanley P; Seiler SM
J Med Chem; 1998 Nov; 41(24):4854-60. PubMed ID: 9822554
[TBL] [Abstract][Full Text] [Related]
58. Tryptase inhibition blocks airway inflammation in a mouse asthma model.
Oh SW; Pae CI; Lee DK; Jones F; Chiang GK; Kim HO; Moon SH; Cao B; Ogbu C; Jeong KW; Kozu G; Nakanishi H; Kahn M; Chi EY; Henderson WR
J Immunol; 2002 Feb; 168(4):1992-2000. PubMed ID: 11823536
[TBL] [Abstract][Full Text] [Related]
59. Human mast cell tryptase fibrinogenolysis: kinetics, anticoagulation mechanism, and cell adhesion disruption.
Thomas VA; Wheeless CJ; Stack MS; Johnson DA
Biochemistry; 1998 Feb; 37(8):2291-8. PubMed ID: 9485375
[TBL] [Abstract][Full Text] [Related]
60. Modulation of tryptase and histamine release from human lung mast cells by protease inhibitors.
He S; Xie H
Asian Pac J Allergy Immunol; 2004 Dec; 22(4):205-12. PubMed ID: 15783133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
